Exhibits

Click to highlight the findings that indicate the client is stable for discharge.

The client has rested well throughout the night with a continuous positive airway pressure (CPAP) device in place. Sequential devices are in place for venous thromboembolism prevention. The client ambulated 100 yards (91 meters) last night and 200 yards (183 meters) this morning.

She reports pain rating of 2 on 0 to 10 scale, located in the abdomen, described as aching. She has tolerated fluids throughout the night with no nausea or vomiting.

Assessment

Neurological Alert and oriented times 4. Cardiovascular WNL

Respiratory WNL

Gastrointestinal/Genitourinary Voided twice throughout night

Body mass index (BMI) is a measure of body fat based on height and weight., A BMI of 25 to 29.9 is considered overweight. Being overweight is a known modifiable risk factor for type 2 diabetes mellitus. The client can potentially lower his risk of developing diabetes by adopting a healthier lifestyle, which may include diet and exercise to achieve a healthier BMI.

Family history is a known risk factor for type 2 diabetes mellitus. Having a first- degree relative with diabetes increases a person's risk of developing the condition. This risk factor is non-modifiable as one cannot change their genetic makeup or family history.

There is no conclusive evidence that links occasional cannabis use to an increased risk of developing type 2 diabetes mellitus. However, lifestyle choices are generally considered modifiable risk factors. It's important to consider the overall lifestyle and health behaviors of the individual.

HDL cholesterol is often referred to as "good" cholesterol. Higher levels of HDL cholesterol are associated with a lower risk of heart disease, which is a common comorbidity of diabetes.An HDL level lower than the recommended range is a modifiable risk factor as it can often be increased through lifestyle changes such as diet and exercise.

While HDL levels are not a direct risk factor for diabetes, they are related to the overall metabolic health of an individual, which can influence the risk of developing type 2 diabetes.

A. Toxoplasmosis: While toxoplasmosis can cause symptoms similar to those described, it is not typically associated with a maculopapular rash on the face. Moreover, routine screening for toxoplasmosis is not typically performed during pregnancy unless indicated by specific risk factors.
B. Group B Streptococcus: Group B Streptococcus is primarily associated with maternal
colonization and neonatal infection, but it does not typically present with a maculopapular rash on the face in the mother.
C. Gonorrhea: Gonorrhea can cause systemic symptoms, but it is not commonly associated with a maculopapular rash on the face. Additionally, routine screening for gonorrhea during pregnancy typically focuses on genital sites rather than systemic symptoms.

D. Rubella: Rubella, or German measles, presents with a maculopapular rash on the face (often described as a "slapped cheek" appearance) along with fever, malaise, sore throat, and
lymphadenopathy. Rubella infection during pregnancy can lead to congenital rubella syndrome, which can have serious consequences for the developing fetus. Therefore, it is important to
review rubella immunity status in pregnant women presenting with these symptoms.